RYOIX

Biotechnology - Investor Class
Price $81.29
Change ($0.22) / -0.27%
As Of 11/25/14

Top 10 Holdings *

as of 11/24/14
Security Name Ticker % of Net Assets
GILEAD SCIENCES, INC. GILD 6.65%
AMGEN INC. AMGN 6.55%
CELGENE CORPORATION CELG 5.64%
BIOGEN IDEC, INC. BIIB 4.49%
ALEXION PHARMACEUTICALS I ALXN 3.74%
REGENERON PHARMACEUTICALS REGN 3.70%
VERTEX PHARMACEUTICALS VRTX 3.11%
ILLUMINA INC ILMN 2.86%
INCYTE GENOMICS, INC. INCY 2.46%
BIOMARIN PHARMACEUTICAL BMRN 2.24%
* excludes any temporary cash or derivative investments View more holdings...

Sectors / Industries

as of 10/31/14

Quarterly Holdings

Investment Strategy

Seeks to provide capital appreciation by investing in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products or services.

Fees and Expenses

Gross Expense Ratio
1.36%
Net Expense Ratio
1.36%


Fund Highlights & Applications

  • N/A


Distributions as of 11/18/14

Most Recent Income
$3.159500
Dividend
$0.000000
Most Recent Capital Gain
$3.159500


Symbols & CUSIPS

ClassSymbolCUSIP
ARYBOX78355E353
CRYCFX783554280
AdvRYOAX783554835
InvRYOIX783554827

Investment Team

Michael P. Byrum
Mike Dellapa
Ryan Harder
Matthew Wu
Anne Ruff
Larry Shank
James R. King
Richard P. Toole
Thomas M. Matteini

Operations

Fund Type
Rydex
Distribution Frequency
Annual (if applicable)
Benchmark
Telephone
800.820.0888
Trading Hours
Phone 09:30 AM - 3:30 PM ET
Web 09:30 AM - 3:50 PM ET
Note: Each financial intermediary may have its own rules about shares transactions, and may have earlier cut-off times for processing your transaction.
Investment Adviser
Security Investors, LLC
Distributor
Guggenheim Funds Distributors, LLC

Disclosure

Performance displayed represents past performance which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Current performance may be lower or higher than the performance data quoted. Returns for performance under one year are cumulative, not annualized.  Performance shown reflects maximum sales charges or contingent deferred sales charges (CDSC) as applicable. Class A-shares have a maximum sales charge of 4.75%. Class C-shares have a maximum CDSC of 1% for shares redeemed within 12 months of purchase.

Data is subject to change on a daily basis. Partial year returns are cumulative, not annualized. Returns reflect the reinvestment of dividends. The securities mentioned are provided for informational purposes only and should not be deemed as a recommendation to buy or sell.

This fund may not be suitable for all investors. •Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds’ holdings in issuers of the same or similar offerings. •The fund may invest in American Depositary Receipts (“ADRs”) therefore subjecting the value of the fund’s portfolio to fluctuations in foreign exchange rates. •The fund is subject to active trading risks that may increase volatility and impact the fund’s ability to achieve its investment objective. •This fund is considered non-diversified and can invest a greater portion of its assets in securities of individual issuers than a diversified fund. As a result, changes in the market value of a single security could cause greater fluctuations in the value of fund shares than would occur in a more diversified fund.

Total annual operating expenses vary by share class. See the prospectus for information on the fees and expenses that apply to each share class.


 

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.

Guggenheim

Subscribe to Perspectives

 

©2014 Guggenheim Investments. All Rights Reserved.

• Not FDIC Insured • No Bank Guarantee • May Lose Value